Key Takeaways:
- AbbVie Inc. (ABBV, Financial) shares fell 17.74% in the past month, yet the company exceeded earnings expectations.
- Despite a year-over-year increase of 7.35% in share price, investor focus has shifted to AI stocks.
- Analysts predict a potential 22.69% upside from current levels, with an average price target of $214.76 for AbbVie.
AbbVie Inc. (ABBV) Stock Performance Overview
In the past month, AbbVie Inc. (ABBV) experienced a notable 17.74% decline in its stock price. Despite this drop, the company delivered impressive full-year adjusted earnings per share of $10.12, surpassing analyst expectations. Over the past year, however, the stock has appreciated by 7.35%. Nevertheless, a shift in investor interest towards AI stocks, which are perceived as offering greater short-term returns, has impacted AbbVie's share performance.
Analyst Predictions and Price Targets
According to 24 analysts who have shared their price targets for AbbVie Inc. (ABBV, Financial), the average target price is $214.76. Estimates vary, with the highest target set at $251.00 and the lowest at $173.00. These targets suggest a potential upside of 22.69% from the current trading price of $175.05. For more detailed estimate data, visit the AbbVie Inc (ABBV) Forecast page.
Brokerage Firm Recommendations
Based on evaluations from 27 brokerage firms, AbbVie Inc. holds an average brokerage recommendation score of 2.0, categorizing it as an "Outperform" stock. This scoring system ranges from 1 to 5, where 1 signifies a "Strong Buy" and 5 indicates a "Sell." Such a rating suggests a general confidence in AbbVie's performance potential compared to its peers.
GuruFocus Valuation Estimates
According to GuruFocus estimates, AbbVie Inc.'s one-year GF Value stands at $167.97, suggesting a potential downside of 4.04% from its current price of $175.05. The GF Value is GuruFocus' proprietary calculation providing an estimate of the fair value for the stock, considering historical trading multiples, past business growth, and anticipated future performance. For further insights, please visit the AbbVie Inc (ABBV, Financial) Summary page.
Investors may need to weigh the current dynamics in the market, particularly the draw of AI stocks, against the robust performance and analysis surrounding AbbVie Inc. (ABBV, Financial) as they consider their investment strategies.
